(Q45220253)

English

Limitations of MIC as the sole criterion in antimicrobial drug dosage regimen design: the need for full characterization of antimicrobial pharmacodynamic profile especially for drug-resistant organisms

scientific article published on 11 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 December 2017

Limitations of MIC as the sole criterion in antimicrobial drug dosage regimen design: the need for full characterization of antimicrobial pharmacodynamic profile especially for drug-resistant organisms (English)

1 reference

Europe PubMed Central

11 December 2017

antimicrobial resistance

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Ronette Gehring

1

1 reference

Europe PubMed Central

11 December 2017

Jim E Riviere

2

1 reference

Europe PubMed Central

11 December 2017

publication date

11 August 2013

1 reference

Europe PubMed Central

11 December 2017

The Veterinary Journal

1 reference

Europe PubMed Central

11 December 2017

198

1 reference

Europe PubMed Central

11 December 2017

1

1 reference

Europe PubMed Central

11 December 2017

15-18

1 reference

Europe PubMed Central

11 December 2017

Determination of minimum inhibitory concentrations

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2013.07.034

7 January 2021

Mechanism-based pharmacokinetic-pharmacodynamic modeling of antimicrobial drug effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2013.07.034

7 January 2021

Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic models

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2013.07.034

7 January 2021

Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2013.07.034

7 January 2021

Novel pharmacokinetic-pharmacodynamic model for prediction of outcomes with an extended-release formulation of ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2013.07.034

7 January 2021

Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2013.07.034

7 January 2021

Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2013.07.034

7 January 2021

Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2013.07.034

7 January 2021

The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2013.07.034

7 January 2021

Identifiers

10.1016/J.TVJL.2013.07.034

1 reference

Europe PubMed Central

11 December 2017

1 reference

Europe PubMed Central

11 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45220253&oldid=2144187805"